A19.1

Clinical Causes: Mycobacterium tuberculosis bacteria entering the bloodstream, usually through a primary lung infection. Spread from a localized tuberculosis infection, especially if treatment is delayed or incomplete. Weak immune system, which makes it harder for the body to contain the bacteria. Close contact with someone who has active tuberculosis.

Key Symptoms: Fever and chills that persist or recur. Night sweats and unexplained weight loss. Fatigue and weakness. Respiratory issues such as cough, sometimes with blood-streaked sputum. Shortness of breath and chest pain in some cases. Multiple organ-related symptoms depending on the sites affected, like abdominal pain or neurological signs.

Diagnosis Path: Diagnosing acute miliary tuberculosis involves a combination of medical history, physical examination, and laboratory tests. Chest X-rays often reveal a characteristic millet seed pattern throughout both lungs. Sputum samples, blood tests, and tissue biopsies can identify Mycobacterium tuberculosis. Additional tests such as a Mantoux tuberculin skin test or interferon-gamma release assays (IGRAs) help determine TB exposure. Advanced imaging techniques and blood cultures may also be used to assess the extent of spread.

Treatment Protocols: Treatment typically involves a lengthy course of multiple antibiotics specifically targeted at Mycobacterium tuberculosis. Standard therapy often lasts at least 6 months, combining medications like isoniazid, rifampin, ethambutol, and pyrazinamide. In some cases, corticosteroids or other supportive therapies may be used to manage symptoms or complications. It's crucial for patients to adhere strictly to the prescribed regimen to prevent drug resistance and ensure successful recovery.